According to the American Cancer Society, one in every eight women will be diagnosed with breast cancer along their lives. This number can be misleading however, as in many cases positive results are actually false positives (is some countries, over 90%). Besides the error margin and the anxiety it can create in the patient, current screening method are painful and costly to public health systems.
The Blue Box proposes a new breast cancer test that is pain-free, accurate and low-cost. Using Artificial Intelligence, it maps and processes key biomarkers from patient biological samples, that are analyzed and digitally shared with patient and doctors in less than an hour.